Trial Profile
Randomized, multicenter, open-labeled, two-arm parallel group trial of pitavastatin 2 mg OD for reducing the risk of major cardiovascular events in patients with clustering cardiovascular risk factors
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 02 Sep 2016
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Atherosclerosis; Cardiovascular disorders
- Focus Therapeutic Use
- 14 Sep 2011 New trial record